Literature DB >> 9058832

Exogenous CD40 ligand induces a pulmonary inflammation response.

J A Wiley1, R Geha, A G Harmsen.   

Abstract

Expression of CD40 on cells involved in the inflammatory response has lead to speculation that CD40 ligation could play an important role in the establishment of the inflammatory response. Upon treatment of wild-type CD40 mice with soluble CD40L-CD8 (sCD40L) fusion protein a pulmonary inflammatory response was induced that was not observed in identically treated CD40 knockout mice. This inflammatory response involved polymorphonuclear leukocyte migration into the alveolar space and the accumulation of alveolar macrophages with up-regulated Ia expression. Treatment of wild-type or IFN-gamma knockout mice with sCD40L induced pulmonary responses that were similar except that fewer neutrophils and macrophages accumulated in the lungs of the IFN-gamma knockout mice. This suggested that IFN-gamma plays a role in sCD40L-induced accumulation of inflammatory cells in the lung. The induction of pulmonary inflammation by exogenous sCD40L supports evidence derived in vitro by others that CD40 ligation can result in inflammatory responses and that sCD40L is a potent inflammagen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058832

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

Authors:  T W Wright; F Gigliotti; J N Finkelstein; J T McBride; C L An; A G Harmsen
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.

Authors:  Matthew W Auten; Weitao Huang; Guixiang Dai; Alistair J Ramsay
Journal:  Vaccine       Date:  2012-02-18       Impact factor: 3.641

3.  Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.

Authors:  Kiminori Kimura; Hisataka Moriwaki; Masahito Nagaki; Masanao Saio; Yasunari Nakamoto; Makoto Naito; Kazuo Kuwata; Francis V Chisari
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

4.  Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation.

Authors:  J A Wiley; A G Harmsen
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

5.  The soluble CD40 ligand sCD154 in systemic lupus erythematosus.

Authors:  K Kato; E Santana-Sahagún; L Z Rassenti; M H Weisman; N Tamura; S Kobayashi; H Hashimoto; T J Kipps
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 6.  Engineering nano- and microparticles to tune immunity.

Authors:  James J Moon; Bonnie Huang; Darrell J Irvine
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

7.  CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis.

Authors:  Anna Nolan; Michael Weiden; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Nehal Mehta; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

Review 8.  The role of costimulatory molecules in allergic disease and asthma.

Authors:  Vincent Lombardi; Abinav K Singh; Omid Akbari
Journal:  Int Arch Allergy Immunol       Date:  2009-09-29       Impact factor: 2.749

9.  CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity.

Authors:  Jeffrey A Gold; Merdad Parsey; Yoshihiko Hoshino; Satomi Hoshino; Anna Nolan; Herman Yee; Doris B Tse; Michael D Weiden
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis.

Authors:  Masako Mizusawa; Mizuoho Kawamura; Mikio Takamori; Tetsuya Kashiyama; Akira Fujita; Motoki Usuzawa; Hiroki Saitoh; Yugo Ashino; Ikuya Yano; Toshio Hattori
Journal:  Clin Vaccine Immunol       Date:  2008-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.